Morning Briefing
Summaries of health policy coverage from major news organizations
Screening Test For Colon Cancer Wins FDA Approval
The test, called Cologuard, can detect genetic mutations in patients' stool samples that are associated with cancerous and precancerous growths.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
